{"cik": 1000228, "item_1A": "Item 1A. Risk Factors . \u201d for a discussion of additional burdens, risks and regulatory developments\u00a0that may  \u00a0 affect our results of operations and financial condition.  Proprietary Rights We hold trademarks relating to the \u201cHenry Schein \u00ae \u201d name and logo, as well as certain other trademarks.\u00a0We intend  \u00a0 to protect our trademarks to the fullest extent practicable.\u00a0 \u00a0 Employees and Human Capital  Environment, Social and Governance  Henry Schein has remained steadfastly committed over our nine-decade history\u00a0to the core philosophy that our  \u00a0 purpose-driven mission of \"doing good\" for our stakeholders is inextricably\u00a0linked to our Company \"doing well\" in  \u00a0 business through our stakeholder engagement model \u201cour Mosaic of Success\u201d.\u00a0We balance the needs of our five  \u00a0 key stakeholders \u2013 Team Schein Members (TSMs), our Customers, our Suppliers, our Stockholders, and Society \u2013  to continue to drive our sustainability and ESG efforts to foster a healthier planet and healthier\u00a0people.\u00a0Overseen  \u00a0 \u00a0 by the Nominating and Governance Committee of our Board of Directors with the\u00a0Compensation Committee also  \u00a0 playing a role in ESG matters related to human capital engagement and executive\u00a0compensation, key 2022  \u00a0 sustainability and ESG highlights included:  \u25cf With the backdrop of the ongoing COVID-19 pandemic and the humanitarian crises in Ukraine and other  regions, we continued our efforts to drive an overall culture of wellness and engagement\u00a0for our TSMs as  \u00a0 we navigated a new hybrid work environment and ensure supply chain resiliency\u00a0to support our customers  \u00a0 and our communities.\u00a0Henry Schein was named Chair of the Private Sector Roundtable\u00a0on Global Health  \u00a0 \u00a0 Security, and continued its work across sectors to support the creation of market intelligence platforms that  enable the appropriate sharing of real-time supply chain data, including through\u00a0the WHO's Pandemic  \u00a0 Supply Chain Network and various national efforts, including the U.S. Supply Chain\u00a0Control Tower.  \u00a0 \u25cf (i) Publishing our annual Corporate Social Responsibility and Sustainability\u00a0Report according to the Global  \u00a0 Reporting Initiative and Sustainability Accounting Standards Board reporting\u00a0standards and issuing our  \u00a0 first Taskforce for Climate-related Financial Disclosures report; (ii) committing to announcing our carbon  reduction goal by the end of 2023; (iii) continued initiatives and programs\u00a0to advance health equity efforts  \u00a0 to promote access to care for underserved and underrepresented communities,\u00a0investing in diversity for  \u00a0 greater health equity in partnership with health care professionals, and\u00a0increasing awareness of health  \u00a0 equity needs globally; (iv) announced the top line findings of our pay equity\u00a0analysis across the U.S., which  \u00a0 reviews compensation across gender and ethnic groups; (v) expanding our\u00a0Diversity and Inclusion (\u201cD&I\u201d)  \u00a0 learning journey, such as by educating global directors and vice presidents on more advanced topics of D&I  including privilege and equity, as well as offering education to all global TSMs below director level on the  importance of D&I; and (vi) continuing to drive a culture of wellness for our\u00a0TSMs by fostering an  \u00a0 environment where they can feel engaged, included and psychologically\u00a0safe.  \u00a0 At Henry Schein, our employees are our greatest asset.\u00a0We employ more than 22,000 people, approximately 50%  \u00a0 of our workforce is based in the United States and approximately 50%\u00a0is based outside of the United States. \u00a0 \u00a0 \u00a0 Approximately 12% of our employees are subject to collective bargaining agreements.\u00a0We believe that our  \u00a0 relations with our employees are excellent.  We refer to our employees as Team\u00a0Schein Members, or \u201cTSMs.\u201d Our TSMs are the cornerstone\u00a0of the Company.\u00a0 \u00a0 \u00a0 \u00a0 We have a strong values-based culture that cultivates a meaningful employee experience that is centered around  people.\u00a0We know our business success is built on the engagement and commitment of our team, which is dedicated  \u00a0 to meeting the needs of their fellow TSMs, our customers, supplier partners,\u00a0stockholders and society.\u00a0As part of  \u00a0 \u00a0 this commitment, our highlights in 2022 included:  \u00a0 \u00a0 \n\nTable of Contents20 \u25cfNurturing a connected community for a happier, more engaged, collaborative work environment.\u00a0We continue to adapt to the new way of working for our TSMs by listening\u00a0to their needs.\u00a0With TSMs working remotely, hybrid and in-person, our goal is to continue to create a collaborative community where every TSM feels connected to our culture.\u00a0Through various virtual and in-person programming from our Employee Resource Groups, Wellness Committee and Team Schein Engagement team, we continue to bring TSMs together in a meaningful way through virtual education sessions\u00a0and networking events.\u00a0To help create a sense of connection and belonging amongst the team, we\u00a0launched \u201cTSM Experience Panels,\u201d which feature TSMs who share their authentic experiences and offer advice and\u00a0best practices on specific topics. We offer a variety of opportunities to volunteer for team-building and engaging in their local communities in which they live and work such as through the We Care Global Challenge, Back to School, and Holiday Cheer. In addition, they can \u201chelp health happen\u201d by participating in key programs and initiatives (e.g., Gives Kids A Smile, Healthy Lifestyles, Healthy Communities\u00a0and Release the Pressure) that partner with industry associations, customers, and suppliers to support\u00a0access to quality health care for underserved and underrepresented communities.\u00a0We continue to evaluate the engagement of our team through various listening mechanisms including roundtables, hosted\u00a0by our CEO and Executive Management Committee (\u201cEMC\u201d), and various surveys, including The\u00a0Pulse, our global culture survey that evaluates TSM engagement globally with results reviewed by senior leaders,\u00a0reported to the Board of Directors (\u201cBOD\u201d).\u00a0Throughout 2022, we held 10 solutions-focused roundtables\u00a0hosted by our EMC members with over 100 TSMs to dive in deeper and influence our\u00a0strategy on programs and processes designed to further enhance our culture.\u00a0\u25cfDriving a culture of wellness for our team members and society.\u00a0In 2020, we launched a Mental Wellness Committee with a mission to drive a culture of wellness and empower\u00a0every TSM to be their best self, mentally, emotionally and physically.\u00a0The Committee provides resources, guidance and support,\u00a0and works across our businesses to establish enhanced workplace norms to\u00a0help improve and safeguard our TSMs\u2019 wellness.\u00a0We actively engage leadership, including our CEO, EMC, BOD and TSMs alike in conversations around the importance of wellness in the workplace.\u00a0In 2022, we rolled-out an EMC video series that focused on being more intentional in the way we work across\u00a0our business.\u00a0These new workplace norms focused on meeting and technology etiquette, successful\u00a0calendaring, establishing and communicating reasonable expectations and prioritization, the importance\u00a0of taking and respecting time off, and the importance of making time for social connection. In addition to expanding\u00a0education on key mental health topics in partnership with our employee assistance vendor, we also rolled-out manager-specific education to provide tips on how to identify signs of burnout\u00a0and have conversations around wellness with their teams.\u00a0With the rise of suicide rates around the world, the Wellness Committee held seminars for the team on suicide prevention and hosted in-person community walks\u00a0that resulted in donations to local suicide prevention organizations globally.\u00a0\u25cfBeing committed to enhancing our D&I initiatives.\u00a0We believe a diverse workforce fosters innovation and cultivates an environment filled with unique perspectives.\u00a0As a result, D&I helps us meet the needs of customers around the world and provide our TSMs an inclusive environment\u00a0where they feel they belong.\u00a0We measure our success in D&I through, among other things, our global culture survey, where results in 2021 showed D&I is our top strength out of 14 focus areas. To guide our efforts and education related to D&I, our Diversity and Inclusion Council, with engagement from our\u00a0BOD and EMC, drives the Company\u2019s overall D&I strategy.\u00a0To deepen our commitment to D&I across the Company, Global Directors and Vice Presidents each have a goal tied to their compensation to champion D&I and attend education.\u00a0We continue to expand our D&I learning journey, educating global Directors and Vice Presidents on key D&I topics including leading inclusively, bias and equity.\u00a0We also continue to educate our global TSMs on the importance of D&I. Additionally, we promote engagement by utilizing our Employee Resource Groups (\u201cERGs\u201d), which we continue to expand,\u00a0as an inclusive and diverse vehicle for all TSMs to share, connect, learn and develop both personally\u00a0and professionally.\u00a0Each of our ERGs has a sponsor from our Executive Management Committee and our BOD\u00a0and our CEO engages directly in many of our ERG programs.\u00a0While inclusion continues to remain a top priority, we also understand the importance of ensuring our internal team reflects the diversity of our customers\u00a0and society.\u00a0In addition to our current gender parity by 2030 goal, we announced a new goal in 2022 with\u00a0an enhanced focus on \n \nTable of Contents20 \u25cfNurturing a connected community for a happier, more engaged, collaborative work environment.\u00a0We continue to adapt to the new way of working for our TSMs by listening\u00a0to their needs.\u00a0With TSMs working remotely, hybrid and in-person, our goal is to continue to create a collaborative community where every TSM feels connected to our culture.\u00a0Through various virtual and in-person programming from our Employee Resource Groups, Wellness Committee and Team Schein Engagement team, we continue to bring TSMs together in a meaningful way through virtual education sessions\u00a0and networking events.\u00a0To help create a sense of connection and belonging amongst the team, we\u00a0launched \u201cTSM Experience Panels,\u201d which feature TSMs who share their authentic experiences and offer advice and\u00a0best practices on specific topics. We offer a variety of opportunities to volunteer for team-building and engaging in their local communities in which they live and work such as through the We Care Global Challenge, Back to School, and Holiday Cheer. In addition, they can \u201chelp health happen\u201d by participating in key programs and initiatives (e.g., Gives Kids A Smile, Healthy Lifestyles, Healthy Communities\u00a0and Release the Pressure) that partner with industry associations, customers, and suppliers to support\u00a0access to quality health care for underserved and underrepresented communities.\u00a0We continue to evaluate the engagement of our team through various listening mechanisms including roundtables, hosted\u00a0by our CEO and Executive Management Committee (\u201cEMC\u201d), and various surveys, including The\u00a0Pulse, our global culture survey that evaluates TSM engagement globally with results reviewed by senior leaders,\u00a0reported to the Board of Directors (\u201cBOD\u201d).\u00a0Throughout 2022, we held 10 solutions-focused roundtables\u00a0hosted by our EMC members with over 100 TSMs to dive in deeper and influence our\u00a0strategy on programs and processes designed to further enhance our culture.\u00a0\u25cfDriving a culture of wellness for our team members and society.\u00a0In 2020, we launched a Mental Wellness Committee with a mission to drive a culture of wellness and empower\u00a0every TSM to be their best self, mentally, emotionally and physically.\u00a0The Committee provides resources, guidance and support,\u00a0and works across our businesses to establish enhanced workplace norms to\u00a0help improve and safeguard our TSMs\u2019 wellness.\u00a0We actively engage leadership, including our CEO, EMC, BOD and TSMs alike in conversations around the importance of wellness in the workplace.\u00a0In 2022, we rolled-out an EMC video series that focused on being more intentional in the way we work across\u00a0our business.\u00a0These new workplace norms focused on meeting and technology etiquette, successful\u00a0calendaring, establishing and communicating reasonable expectations and prioritization, the importance\u00a0of taking and respecting time off, and the importance of making time for social connection. In addition to expanding\u00a0education on key mental health topics in partnership with our employee assistance vendor, we also rolled-out manager-specific education to provide tips on how to identify signs of burnout\u00a0and have conversations around wellness with their teams.\u00a0With the rise of suicide rates around the world, the Wellness Committee held seminars for the team on suicide prevention and hosted in-person community walks\u00a0that resulted in donations to local suicide prevention organizations globally.\u00a0\u25cfBeing committed to enhancing our D&I initiatives.\u00a0We believe a diverse workforce fosters innovation and cultivates an environment filled with unique perspectives.\u00a0As a result, D&I helps us meet the needs of customers around the world and provide our TSMs an inclusive environment\u00a0where they feel they belong.\u00a0We measure our success in D&I through, among other things, our global culture survey, where results in 2021 showed D&I is our top strength out of 14 focus areas. To guide our efforts and education related to D&I, our Diversity and Inclusion Council, with engagement from our\u00a0BOD and EMC, drives the Company\u2019s overall D&I strategy.\u00a0To deepen our commitment to D&I across the Company, Global Directors and Vice Presidents each have a goal tied to their compensation to champion D&I and attend education.\u00a0We continue to expand our D&I learning journey, educating global Directors and Vice Presidents on key D&I topics including leading inclusively, bias and equity.\u00a0We also continue to educate our global TSMs on the importance of D&I. Additionally, we promote engagement by utilizing our Employee Resource Groups (\u201cERGs\u201d), which we continue to expand,\u00a0as an inclusive and diverse vehicle for all TSMs to share, connect, learn and develop both personally\u00a0and professionally.\u00a0Each of our ERGs has a sponsor from our Executive Management Committee and our BOD\u00a0and our CEO engages directly in many of our ERG programs.\u00a0While inclusion continues to remain a top priority, we also understand the importance of ensuring our internal team reflects the diversity of our customers\u00a0and society.\u00a0In addition to our current gender parity by 2030 goal, we announced a new goal in 2022 with\u00a0an enhanced focus on  Table of Contents 20  \u25cf Nurturing a connected community for a happier, more engaged, collaborative work environment.\u00a0 \u00a0 We  continue to adapt to the new way of working for our TSMs by listening\u00a0to their needs.\u00a0With TSMs working  \u00a0 \u00a0 remotely, hybrid and in-person, our goal is to continue to create a collaborative community where every  TSM feels connected to our culture.\u00a0Through various virtual and in-person programming from our  \u00a0 Employee Resource Groups, Wellness Committee and Team Schein Engagement team, we continue to  bring TSMs together in a meaningful way through virtual education sessions\u00a0and networking events.\u00a0To  \u00a0 \u00a0 help create a sense of connection and belonging amongst the team, we\u00a0launched \u201cTSM Experience Panels,\u201d  \u00a0 which feature TSMs who share their authentic experiences and offer advice and\u00a0best practices on specific  \u00a0 topics. We offer a variety of opportunities to volunteer for team-building and engaging in their local  communities in which they live and work such as through the We Care Global Challenge, Back to School,  and Holiday Cheer. In addition, they can \u201chelp health happen\u201d by participating in key programs and  initiatives (e.g., Gives Kids A Smile, Healthy Lifestyles, Healthy Communities\u00a0and Release the Pressure)  \u00a0 that partner with industry associations, customers, and suppliers to support\u00a0access to quality health care for  \u00a0 underserved and underrepresented communities.\u00a0We continue to evaluate the engagement of our team  \u00a0 through various listening mechanisms including roundtables, hosted\u00a0by our CEO and Executive  \u00a0 Management Committee (\u201cEMC\u201d), and various surveys, including The\u00a0Pulse, our global culture survey that  \u00a0 evaluates TSM engagement globally with results reviewed by senior leaders,\u00a0reported to the Board of  \u00a0 Directors (\u201cBOD\u201d).\u00a0Throughout 2022, we held 10 solutions-focused roundtables\u00a0hosted by our EMC  \u00a0 \u00a0 members with over 100 TSMs to dive in deeper and influence our\u00a0strategy on programs and processes  \u00a0 designed to further enhance our culture.\u00a0 \u00a0 \u25cf Driving a culture of wellness for our team members and society.\u00a0 \u00a0 In 2020, we launched a Mental Wellness  Committee with a mission to drive a culture of wellness and empower\u00a0every TSM to be their best self,  \u00a0 mentally, emotionally and physically.\u00a0The Committee provides resources, guidance and support,\u00a0and  \u00a0 \u00a0 works across our businesses to establish enhanced workplace norms to\u00a0help improve and safeguard our  \u00a0 TSMs\u2019 wellness.\u00a0We actively engage leadership, including our CEO, EMC, BOD and TSMs alike in  \u00a0 conversations around the importance of wellness in the workplace.\u00a0In 2022, we rolled-out an EMC video  \u00a0 series that focused on being more intentional in the way we work across\u00a0our business.\u00a0These new  \u00a0 \u00a0 workplace norms focused on meeting and technology etiquette, successful\u00a0calendaring, establishing and  \u00a0 communicating reasonable expectations and prioritization, the importance\u00a0of taking and respecting time  \u00a0 off, and the importance of making time for social connection. In addition to expanding\u00a0education on key  \u00a0 mental health topics in partnership with our employee assistance vendor, we also rolled-out manager- specific education to provide tips on how to identify signs of burnout\u00a0and have conversations around  \u00a0 wellness with their teams.\u00a0With the rise of suicide rates around the world, the Wellness Committee held  \u00a0 seminars for the team on suicide prevention and hosted in-person community walks\u00a0that resulted in  \u00a0 donations to local suicide prevention organizations globally.\u00a0 \u00a0 \u25cf Being committed to enhancing our D&I initiatives. \u00a0We believe a diverse workforce fosters innovation and  \u00a0 cultivates an environment filled with unique perspectives.\u00a0As a result, D&I helps us meet the needs of  \u00a0 customers around the world and provide our TSMs an inclusive environment\u00a0where they feel they belong.\u00a0 \u00a0 \u00a0 We measure our success in D&I through, among other things, our global culture survey, where results in  2021 showed D&I is our top strength out of 14 focus areas. To guide our efforts and education related to  D&I, our Diversity and Inclusion Council, with engagement from our\u00a0BOD and EMC, drives the  \u00a0 Company\u2019s overall D&I strategy.\u00a0To deepen our commitment to D&I across the Company, Global  \u00a0 Directors and Vice Presidents each have a goal tied to their compensation to champion D&I and attend  education.\u00a0We continue to expand our D&I learning journey, educating global Directors and Vice  \u00a0 Presidents on key D&I topics including leading inclusively, bias and equity.\u00a0We also continue to educate  \u00a0 our global TSMs on the importance of D&I. Additionally, we promote engagement by utilizing our  Employee Resource Groups (\u201cERGs\u201d), which we continue to expand,\u00a0as an inclusive and diverse vehicle  \u00a0 for all TSMs to share, connect, learn and develop both personally\u00a0and professionally.\u00a0Each of our ERGs  \u00a0 \u00a0 has a sponsor from our Executive Management Committee and our BOD\u00a0and our CEO engages directly in  \u00a0 many of our ERG programs.\u00a0While inclusion continues to remain a top priority, we also understand the  \u00a0 importance of ensuring our internal team reflects the diversity of our customers\u00a0and society.\u00a0In addition to  \u00a0 \u00a0 our current gender parity by 2030 goal, we announced a new goal in 2022 with\u00a0an enhanced focus on  \u00a0 \n\nTable of Contents21 increasing the diversity of all underrepresented groups in senior leadership\u00a0levels through our talent planning, compensation and recruitment processes, in alignment with\u00a0our corporate strategic planning objectives to achieve concrete results.\u00a0We continue to disclose additional diversity data, with frequent reporting to the EMC and BOD.\u00a0In 2022, we published our United States Equal Employment Opportunity Commission (\u201cEEOC\u201d) EEO-1 data for the U.S. for the first time.\u00a0We continue to enhance our recruiting strategy by developing and investing in strategic hires who complement\u00a0our D&I mission.\u00a0We believe that these efforts will serve as a critical steppingstone as we continue to strengthen our\u00a0D&I initiatives in an effort to meet the evolving needs of our customers, supplier partners, TSMs, stockholders\u00a0and society.\u00a0\u25cfUnderstanding that growth, recognition and purpose are key pillars to TSM fulfillment.\u00a0Personal and professional development of our TSMs is important to us.\u00a0As such, we invest in our employees by providing both formal and informal learning opportunities that are\u00a0focused on growing and enhancing knowledge, skills and abilities.\u00a0TSMs globally are offered a broad suite of professional development training programs targeted to specific learning opportunities based on their current\u00a0and potential future role within the Company.\u00a0We also offer over 50 organizational and development training courses designed to aid in the overall development and advancement of skills and competencies\u00a0to enable organizational success.\u00a0Executive education, mentorship and coaching programs also\u00a0form an important part of our development and career support initiatives.\u00a0Additionally, we continued to see an increase in participation in our Organizational Development initiatives in 2022 with our TSMs reporting\u00a0a high utilization of skills learned.\u00a0Talent planning efforts are also an integral part of our commitment to ensure a strong diverse leadership pipeline across the organization.\u00a0Through a formal global process, we strategically identify and develop talent through targeted development opportunities and intentional succession\u00a0plans.\u00a0We continuously identify potential management successors as part\u00a0of our succession planning process.\u00a0Information derived from talent planning efforts informs curriculum design and\u00a0content to help focus on the right capabilities and help ensure alignment of career development\u00a0efforts with the future needs of the organization.\u00a0Our BOD is provided with periodic updates regarding our\u00a0talent and succession planning efforts and participates in professional development activities with our TSMs.\u00a0We know recognition and purpose are also key pillars to TSM engagement, so we continue to find\u00a0ways to recognize our TSMs through our annual performance review process, and various recognition\u00a0opportunities including our Teddy Philson Team Schein Award,\u00a0which highlights TSMs who exemplify our Team Schein Values.\u00a0In addition, we continue to focus on ensuring every TSM understands the importance\u00a0in the role they play within the organization, how they contribute to a larger purpose of creating a healthier world, as well as\u00a0continue to provide opportunities for TSMs to engage in meaningful ways\u00a0that connect back to their own personal purpose, such as helping the community through CSR activities. Available Information We make available free of charge through our Internet website, www.henryschein.com, our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, statements\u00a0of beneficial ownership of securities on Forms 3, 4 and 5 and amendments to these reports and statements\u00a0filed or furnished pursuant to Section 13(a) and Section 16 of the Securities Exchange Act of 1934\u00a0as soon as reasonably practicable after such materials are electronically filed with, or furnished to, the United States Securities\u00a0and Exchange Commission, or SEC.\u00a0Our principal executive offices are located at 135 Duryea Road, Melville, New\u00a0York\u00a011747, and our telephone number is (631) 843-5500.\u00a0Unless the context specifically requires otherwise, the terms the\u00a0\u201cCompany,\u201d \u201cHenry Schein,\u201d \u201cwe,\u201d \u201cus\u201d and \u201cour\u201d mean Henry Schein, Inc., a Delaware\u00a0corporation, and its consolidated subsidiaries. \n \nTable of Contents21 increasing the diversity of all underrepresented groups in senior leadership\u00a0levels through our talent planning, compensation and recruitment processes, in alignment with\u00a0our corporate strategic planning objectives to achieve concrete results.\u00a0We continue to disclose additional diversity data, with frequent reporting to the EMC and BOD.\u00a0In 2022, we published our United States Equal Employment Opportunity Commission (\u201cEEOC\u201d) EEO-1 data for the U.S. for the first time.\u00a0We continue to enhance our recruiting strategy by developing and investing in strategic hires who complement\u00a0our D&I mission.\u00a0We believe that these efforts will serve as a critical steppingstone as we continue to strengthen our\u00a0D&I initiatives in an effort to meet the evolving needs of our customers, supplier partners, TSMs, stockholders\u00a0and society.\u00a0\u25cfUnderstanding that growth, recognition and purpose are key pillars to TSM fulfillment.\u00a0Personal and professional development of our TSMs is important to us.\u00a0As such, we invest in our employees by providing both formal and informal learning opportunities that are\u00a0focused on growing and enhancing knowledge, skills and abilities.\u00a0TSMs globally are offered a broad suite of professional development training programs targeted to specific learning opportunities based on their current\u00a0and potential future role within the Company.\u00a0We also offer over 50 organizational and development training courses designed to aid in the overall development and advancement of skills and competencies\u00a0to enable organizational success.\u00a0Executive education, mentorship and coaching programs also\u00a0form an important part of our development and career support initiatives.\u00a0Additionally, we continued to see an increase in participation in our Organizational Development initiatives in 2022 with our TSMs reporting\u00a0a high utilization of skills learned.\u00a0Talent planning efforts are also an integral part of our commitment to ensure a strong diverse leadership pipeline across the organization.\u00a0Through a formal global process, we strategically identify and develop talent through targeted development opportunities and intentional succession\u00a0plans.\u00a0We continuously identify potential management successors as part\u00a0of our succession planning process.\u00a0Information derived from talent planning efforts informs curriculum design and\u00a0content to help focus on the right capabilities and help ensure alignment of career development\u00a0efforts with the future needs of the organization.\u00a0Our BOD is provided with periodic updates regarding our\u00a0talent and succession planning efforts and participates in professional development activities with our TSMs.\u00a0We know recognition and purpose are also key pillars to TSM engagement, so we continue to find\u00a0ways to recognize our TSMs through our annual performance review process, and various recognition\u00a0opportunities including our Teddy Philson Team Schein Award,\u00a0which highlights TSMs who exemplify our Team Schein Values.\u00a0In addition, we continue to focus on ensuring every TSM understands the importance\u00a0in the role they play within the organization, how they contribute to a larger purpose of creating a healthier world, as well as\u00a0continue to provide opportunities for TSMs to engage in meaningful ways\u00a0that connect back to their own personal purpose, such as helping the community through CSR activities. Available Information We make available free of charge through our Internet website, www.henryschein.com, our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, statements\u00a0of beneficial ownership of securities on Forms 3, 4 and 5 and amendments to these reports and statements\u00a0filed or furnished pursuant to Section 13(a) and Section 16 of the Securities Exchange Act of 1934\u00a0as soon as reasonably practicable after such materials are electronically filed with, or furnished to, the United States Securities\u00a0and Exchange Commission, or SEC.\u00a0Our principal executive offices are located at 135 Duryea Road, Melville, New\u00a0York\u00a011747, and our telephone number is (631) 843-5500.\u00a0Unless the context specifically requires otherwise, the terms the\u00a0\u201cCompany,\u201d \u201cHenry Schein,\u201d \u201cwe,\u201d \u201cus\u201d and \u201cour\u201d mean Henry Schein, Inc., a Delaware\u00a0corporation, and its consolidated subsidiaries.  Table of Contents 21  increasing the diversity of all underrepresented groups in senior leadership\u00a0levels through our talent  \u00a0 planning, compensation and recruitment processes, in alignment with\u00a0our corporate strategic planning  \u00a0 objectives to achieve concrete results.\u00a0We continue to disclose additional diversity data, with frequent  \u00a0 reporting to the EMC and BOD.\u00a0In 2022, we published our United States Equal Employment Opportunity  \u00a0 Commission (\u201cEEOC\u201d) EEO-1 data for the U.S. for the first time.\u00a0We continue to enhance our recruiting  \u00a0 strategy by developing and investing in strategic hires who complement\u00a0our D&I mission.\u00a0We believe that  \u00a0 \u00a0 these efforts will serve as a critical steppingstone as we continue to strengthen our\u00a0D&I initiatives in an  \u00a0 effort to meet the evolving needs of our customers, supplier partners, TSMs, stockholders\u00a0and society.\u00a0 \u00a0 \u00a0 \u25cf Understanding that growth, recognition and purpose are key pillars to TSM fulfillment. \u00a0Personal and  \u00a0 professional development of our TSMs is important to us.\u00a0As such, we invest in our employees by  \u00a0 providing both formal and informal learning opportunities that are\u00a0focused on growing and enhancing  \u00a0 knowledge, skills and abilities.\u00a0TSMs globally are offered a broad suite of professional development  \u00a0 training programs targeted to specific learning opportunities based on their current\u00a0and potential future role  \u00a0 within the Company.\u00a0We also offer over 50 organizational and development training courses designed to  \u00a0 aid in the overall development and advancement of skills and competencies\u00a0to enable organizational  \u00a0 success.\u00a0Executive education, mentorship and coaching programs also\u00a0form an important part of our  \u00a0 \u00a0 development and career support initiatives.\u00a0Additionally, we continued to see an increase in participation  \u00a0 in our Organizational Development initiatives in 2022 with our TSMs reporting\u00a0a high utilization of skills  \u00a0 learned.\u00a0Talent planning efforts are also an integral part of our commitment to ensure a strong diverse  \u00a0 leadership pipeline across the organization.\u00a0Through a formal global process, we strategically identify and  \u00a0 develop talent through targeted development opportunities and intentional succession\u00a0plans.\u00a0We  \u00a0 \u00a0 continuously identify potential management successors as part\u00a0of our succession planning process.\u00a0 \u00a0 \u00a0 Information derived from talent planning efforts informs curriculum design and\u00a0content to help focus on the  \u00a0 right capabilities and help ensure alignment of career development\u00a0efforts with the future needs of the  \u00a0 organization.\u00a0Our BOD is provided with periodic updates regarding our\u00a0talent and succession planning  \u00a0 \u00a0 efforts and participates in professional development activities with our TSMs.\u00a0We know recognition and  \u00a0 purpose are also key pillars to TSM engagement, so we continue to find\u00a0ways to recognize our TSMs  \u00a0 through our annual performance review process, and various recognition\u00a0opportunities including our Teddy  \u00a0 Philson Team Schein Award,\u00a0which highlights TSMs who exemplify our Team Schein Values.\u00a0In addition,  \u00a0 \u00a0 we continue to focus on ensuring every TSM understands the importance\u00a0in the role they play within the  \u00a0 organization, how they contribute to a larger purpose of creating a healthier world, as well as\u00a0continue to  \u00a0 provide opportunities for TSMs to engage in meaningful ways\u00a0that connect back to their own personal  \u00a0 purpose, such as helping the community through CSR activities.  Available Information  We make available free of charge through our Internet website, www.henryschein.com, our annual report on Form  10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, statements\u00a0of beneficial ownership of  \u00a0 securities on Forms 3, 4 and 5 and amendments to these reports and statements\u00a0filed or furnished pursuant to  \u00a0 Section 13(a) and Section 16 of the Securities Exchange Act of 1934\u00a0as soon as reasonably practicable after such  \u00a0 materials are electronically filed with, or furnished to, the United States Securities\u00a0and Exchange Commission, or  \u00a0 SEC.\u00a0Our principal executive offices are located at 135 Duryea Road, Melville, New\u00a0York\u00a011747, and our  \u00a0 \u00a0 \u00a0 telephone number is (631) 843-5500.\u00a0Unless the context specifically requires otherwise, the terms the\u00a0\u201cCompany,\u201d  \u00a0 \u00a0 \u201cHenry Schein,\u201d \u201cwe,\u201d \u201cus\u201d and \u201cour\u201d mean Henry Schein, Inc., a Delaware\u00a0corporation, and its consolidated  \u00a0 subsidiaries.  \n\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\nTable of Contents22 Information about our Executive Officers The following table sets forth certain information regarding our executive\u00a0officers: Name Age Position Stanley M. Bergman\u00a073 Chairman, Chief Executive Officer, Director James P.\u00a0Breslawski\u00a069 Vice Chairman, President, Director David Brous 54 Chief Executive Officer, Strategic Business Group Brad Connett 64 Chief Executive Officer, North America Distribution Group Michael S. Ettinger\u00a061 Executive Vice President and Chief Operating Officer Lorelei McGlynn\u00a059 Senior Vice President, Chief Human Resources Officer Mark E. Mlotek\u00a067 Executive Vice President, Chief Strategic Officer, Director Ronald N. South 61 Senior Vice President, Chief Financial Officer Walter Siegel\u00a063 Senior Vice President and Chief Legal Officer Stanley M. Bergman\u00a0has been our Chairman and Chief Executive Officer since 1989 and a director\u00a0since 1982.\u00a0Mr. Bergman held the position of President from 1989 to 2005.\u00a0Mr. Bergman held the position of Executive Vice President from 1985 to 1989 and Vice President of Finance and Administration from 1980 to 1985.\u00a0James P. Breslawski\u00a0has been our Vice Chairman since 2018, President since 2005 and a director since 1992.\u00a0Mr. Breslawski was the Chief Executive Officer of our Henry Schein Global Dental\u00a0Group from 2005 to 2018.\u00a0Mr. Breslawski held the position of Executive Vice President and President of U.S. Dental from 1990 to 2005, with primary responsibility for the North American Dental Group.\u00a0Between 1980 and 1990, Mr. Breslawski held various positions with us, including Chief Financial Officer, Vice President of Finance and Administration and Corporate Controller. David Brous\u00a0has been our Chief Executive Officer, Strategic Business Group since 2021.\u00a0Mr. Brous joined us in 2002 and has held many positions within the organization, including President, Strategic Business\u00a0Units Group and Asia Pacific & Brazil Dental, leading and managing the Corporate Business\u00a0Development Group and the International Healthcare Group (managing our International Animal Health business,\u00a0International Medical business and Australia / New Zealand Dental business). Brad Connett\u00a0has been our Chief Executive Officer, North American Distribution Group since 2021.\u00a0Previously Mr. Connett was the President of our U.S. Medical Group from 2018 to 2021.\u00a0Mr. Connett joined us in 1997 and has held a number of roles of increasing responsibility at the Company.\u00a0Throughout his career, he has received numerous industry honors, including the John F. Sasen Leadership Award from the Health Industry Distributors Association (HIDA), in recognition of his service to the industry, and induction into the Medical Distribution Hall of Fame by Repertoire Magazine. Michael S. Ettinger\u00a0has been our Executive Vice President and Chief Operating Officer since July 2022.\u00a0Prior to his current position, Mr. Ettinger served as Senior Vice President, Corporate & Legal Affairs, Chief of Staff and Secretary from 2015 to July 2022, Senior Vice President, Corporate & Legal Affairs and Secretary from 2013 to 2015, Corporate Senior Vice President, General Counsel & Secretary from 2006 to 2013, Vice President, General Counsel and Secretary from 2000 to 2006, Vice President and Associate General Counsel from 1998 to 2000\u00a0and Associate General Counsel from 1994 to 1998.\u00a0Before joining us, Mr. Ettinger served as a senior associate with Bower & Gardner and as a member of the Tax Department at Arthur Andersen. Lorelei McGlynn\u00a0has been our Senior Vice President, Chief Human Resources Officer since 2013.\u00a0Since joining us in 1999, Ms. McGlynn has served as Vice President, Global Human Resources and Financial Operations from 2008 to 2013, Chief Financial Officer, International Group and Vice President of Global Financial Operations from 2002 to 2008 and Vice President, Finance, North America from 1999 to 2002.\u00a0Prior to joining us, Ms. McGlynn served as Assistant Vice President of Finance at Adecco Corporation. \n \n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\nTable of Contents22 Information about our Executive Officers The following table sets forth certain information regarding our executive\u00a0officers: Name Age Position Stanley M. Bergman\u00a073 Chairman, Chief Executive Officer, Director James P.\u00a0Breslawski\u00a069 Vice Chairman, President, Director David Brous 54 Chief Executive Officer, Strategic Business Group Brad Connett 64 Chief Executive Officer, North America Distribution Group Michael S. Ettinger\u00a061 Executive Vice President and Chief Operating Officer Lorelei McGlynn\u00a059 Senior Vice President, Chief Human Resources Officer Mark E. Mlotek\u00a067 Executive Vice President, Chief Strategic Officer, Director Ronald N. South 61 Senior Vice President, Chief Financial Officer Walter Siegel\u00a063 Senior Vice President and Chief Legal Officer Stanley M. Bergman\u00a0has been our Chairman and Chief Executive Officer since 1989 and a director\u00a0since 1982.\u00a0Mr. Bergman held the position of President from 1989 to 2005.\u00a0Mr. Bergman held the position of Executive Vice President from 1985 to 1989 and Vice President of Finance and Administration from 1980 to 1985.\u00a0James P. Breslawski\u00a0has been our Vice Chairman since 2018, President since 2005 and a director since 1992.\u00a0Mr. Breslawski was the Chief Executive Officer of our Henry Schein Global Dental\u00a0Group from 2005 to 2018.\u00a0Mr. Breslawski held the position of Executive Vice President and President of U.S. Dental from 1990 to 2005, with primary responsibility for the North American Dental Group.\u00a0Between 1980 and 1990, Mr. Breslawski held various positions with us, including Chief Financial Officer, Vice President of Finance and Administration and Corporate Controller. David Brous\u00a0has been our Chief Executive Officer, Strategic Business Group since 2021.\u00a0Mr. Brous joined us in 2002 and has held many positions within the organization, including President, Strategic Business\u00a0Units Group and Asia Pacific & Brazil Dental, leading and managing the Corporate Business\u00a0Development Group and the International Healthcare Group (managing our International Animal Health business,\u00a0International Medical business and Australia / New Zealand Dental business). Brad Connett\u00a0has been our Chief Executive Officer, North American Distribution Group since 2021.\u00a0Previously Mr. Connett was the President of our U.S. Medical Group from 2018 to 2021.\u00a0Mr. Connett joined us in 1997 and has held a number of roles of increasing responsibility at the Company.\u00a0Throughout his career, he has received numerous industry honors, including the John F. Sasen Leadership Award from the Health Industry Distributors Association (HIDA), in recognition of his service to the industry, and induction into the Medical Distribution Hall of Fame by Repertoire Magazine. Michael S. Ettinger\u00a0has been our Executive Vice President and Chief Operating Officer since July 2022.\u00a0Prior to his current position, Mr. Ettinger served as Senior Vice President, Corporate & Legal Affairs, Chief of Staff and Secretary from 2015 to July 2022, Senior Vice President, Corporate & Legal Affairs and Secretary from 2013 to 2015, Corporate Senior Vice President, General Counsel & Secretary from 2006 to 2013, Vice President, General Counsel and Secretary from 2000 to 2006, Vice President and Associate General Counsel from 1998 to 2000\u00a0and Associate General Counsel from 1994 to 1998.\u00a0Before joining us, Mr. Ettinger served as a senior associate with Bower & Gardner and as a member of the Tax Department at Arthur Andersen. Lorelei McGlynn\u00a0has been our Senior Vice President, Chief Human Resources Officer since 2013.\u00a0Since joining us in 1999, Ms. McGlynn has served as Vice President, Global Human Resources and Financial Operations from 2008 to 2013, Chief Financial Officer, International Group and Vice President of Global Financial Operations from 2002 to 2008 and Vice President, Finance, North America from 1999 to 2002.\u00a0Prior to joining us, Ms. McGlynn served as Assistant Vice President of Finance at Adecco Corporation.  \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Table of Contents 22  Information about our Executive Officers  The following table sets forth certain information regarding our executive\u00a0officers:  \u00a0 Name  Age  Position  Stanley M. Bergman\u00a0 \u00a0 73  Chairman, Chief Executive Officer, Director  James P.\u00a0Breslawski\u00a0 \u00a0 \u00a0 69  Vice Chairman, President, Director  David Brous  54  Chief Executive Officer, Strategic Business Group  Brad Connett  64  Chief Executive Officer, North America Distribution Group  Michael S. Ettinger\u00a0 \u00a0 61  Executive Vice President and Chief Operating Officer  Lorelei McGlynn\u00a0 \u00a0 59  Senior Vice President, Chief Human Resources Officer  Mark E. Mlotek\u00a0 \u00a0 67  Executive Vice President, Chief Strategic Officer, Director  Ronald N. South  61  Senior Vice President, Chief Financial Officer  Walter Siegel\u00a0 \u00a0 63  Senior Vice President and Chief Legal Officer  Stanley M. Bergman \u00a0has been our Chairman and Chief Executive Officer since 1989 and a director\u00a0since 1982.\u00a0 \u00a0 \u00a0 \u00a0 Mr. Bergman held the position of President from 1989 to 2005.\u00a0Mr. Bergman held the position of Executive Vice  \u00a0 President from 1985 to 1989 and Vice President of Finance and Administration from 1980 to 1985.\u00a0 \u00a0 James P. Breslawski \u00a0has been our Vice Chairman since 2018, President since 2005 and a director since 1992.\u00a0Mr.  \u00a0 \u00a0 Breslawski was the Chief Executive Officer of our Henry Schein Global Dental\u00a0Group from 2005 to 2018.\u00a0Mr.  \u00a0 \u00a0 Breslawski held the position of Executive Vice President and President of U.S. Dental from 1990 to 2005, with  primary responsibility for the North American Dental Group.\u00a0Between 1980 and 1990, Mr. Breslawski held  \u00a0 various positions with us, including Chief Financial Officer, Vice President of Finance and Administration and  Corporate Controller.  David Brous \u00a0has been our Chief Executive Officer, Strategic Business Group since 2021.\u00a0Mr. Brous joined us in  \u00a0 \u00a0 2002 and has held many positions within the organization, including President, Strategic Business\u00a0Units Group and  \u00a0 Asia Pacific & Brazil Dental, leading and managing the Corporate Business\u00a0Development Group and the  \u00a0 International Healthcare Group (managing our International Animal Health business,\u00a0International Medical  \u00a0 business and Australia / New Zealand Dental business).  Brad Connett \u00a0has been our Chief Executive Officer, North American Distribution Group since 2021.\u00a0Previously  \u00a0 \u00a0 Mr. Connett was the President of our U.S. Medical Group from 2018 to 2021.\u00a0Mr. Connett joined us in 1997 and  \u00a0 has held a number of roles of increasing responsibility at the Company.\u00a0Throughout his career, he has received  \u00a0 numerous industry honors, including the John F. Sasen Leadership Award from the Health Industry Distributors  Association (HIDA), in recognition of his service to the industry, and induction into the Medical Distribution Hall  of Fame by Repertoire Magazine.  Michael S. Ettinger \u00a0has been our Executive Vice President and Chief Operating Officer since July 2022.\u00a0Prior to  \u00a0 \u00a0 his current position, Mr. Ettinger served as Senior Vice President, Corporate & Legal Affairs, Chief of Staff and  Secretary from 2015 to July 2022, Senior Vice President, Corporate & Legal Affairs and Secretary from 2013 to  2015, Corporate Senior Vice President, General Counsel & Secretary from 2006 to 2013, Vice President, General  Counsel and Secretary from 2000 to 2006, Vice President and Associate General Counsel from 1998 to 2000\u00a0and  \u00a0 Associate General Counsel from 1994 to 1998.\u00a0Before joining us, Mr. Ettinger served as a senior associate with  \u00a0 Bower & Gardner and as a member of the Tax Department at Arthur Andersen.  Lorelei McGlynn \u00a0has been our Senior Vice President, Chief Human Resources Officer since 2013.\u00a0Since joining  \u00a0 \u00a0 us in 1999, Ms. McGlynn has served as Vice President, Global Human Resources and Financial Operations from  2008 to 2013, Chief Financial Officer, International Group and Vice President of Global Financial Operations from  2002 to 2008 and Vice President, Finance, North America from 1999 to 2002.\u00a0Prior to joining us, Ms. McGlynn  \u00a0 served as Assistant Vice President of Finance at Adecco Corporation.  \n\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\nTable of Contents23 Mark E. Mlotek\u00a0has been our Executive Vice President and Chief Strategic Officer since 2012.\u00a0Mr. Mlotek was Senior Vice President and subsequently Executive Vice President of the Corporate Business Development Group between 2000 and 2012.\u00a0Prior to that, Mr. Mlotek was Vice President, General Counsel and Secretary from 1994 to 1999 and became a director in 1995.\u00a0Prior to joining us, Mr. Mlotek was a partner in the law firm of Proskauer Rose LLP,\u00a0counsel to us, specializing in mergers and acquisitions, corporate reorganizations and tax law from\u00a01989 to 1994. Ronald N. South\u00a0has been our Senior Vice President\u00a0and Chief Financial Officer (and principal financial officer and principal accounting officer) since April 2022.\u00a0Prior to holding his current position, Mr. South was our Corporate Finance and Chief Accounting Officer from 2013 until April 2022.\u00a0Prior to joining us in 2008 as our Vice President, Corporate Finance, Mr. South held leadership roles at Bristol-Myers Squibb, where he served as Vice President, Finance, for the Cardiovascular and Metabolic business lines, as well as Vice President, Controller, for its U.S. Pharmaceutical Division, and Vice President, Corporate General Auditor.\u00a0Prior to Bristol-Myers Squibb, he served as North American Director of Corporate Audit at\u00a0PepsiCo, and held several roles of increasing responsibility with PricewaterhouseCoopers LLP, where he advised clients located in the United States, Europe, and Latin America.\u00a0Mr. South is a certified public accountant. Walter Siegel\u00a0has been our Senior Vice President and Chief Legal Officer since 2021.\u00a0Previously, Mr.\u00a0Siegel was our Senior Vice President and General Counsel from 2013 until 2021.\u00a0Prior to joining us, Mr. Siegel was employed with Standard Microsystems Corporation, a publicly traded global semiconductor\u00a0company from 2005 to 2012, holding positions of increasing responsibility, most recently as Senior Vice President, General Counsel and Secretary. Other Executive Management The following table sets forth certain information regarding other Executive\u00a0Management: Name Age Position Andrea Albertini 52 Chief Executive Officer, International Distribution Group Leigh Benowitz 55 Senior Vice President and Chief Global Digital Transformation Officer\u00a0Trinh Clark 49 Senior Vice President and Chief Global Customer Experience Officer James Mullins 58 Senior Vice President, Global Supply Chain Kelly Murphy 42 Senior Vice President and General Counsel Christopher Pendergast 60 Senior Vice President and Chief Technology Officer Michael Racioppi\u00a068 Senior Vice President, Chief Merchandising Officer Ren\u00e9 Willi, Ph.D. 55 Chief Executive Officer, Global Oral Reconstruction Group Andrea Albertini\u00a0has been Chief Executive Officer, International Distribution Group since 2023.\u00a0Mr. Albertini joined us in 2013 and has held several positions within the organization including\u00a0President, International Distribution Group, President of our EMEA Dental Distribution Group,\u00a0and Vice-President of International Dental Equipment.\u00a0Prior to joining Henry Schein, Mr. Albertini held leadership positions at Cefla Dental Group and Castellini. Leigh Benowitz\u00a0has been our Senior Vice President and Chief Global Digital Transformation Officer since August 2022.\u00a0Ms. Benowitz joined us in 2017 and has held several key positions\u00a0including Vice President Digital & Customer Experience and Global eCommerce Platform Digital Transformation Officer.\u00a0Prior to joining Henry Schein, Ms. Benowitz held various positions with increasing responsibilities\u00a0at Citi. Trinh Clark has been our Senior Vice President and Chief Global Customer Experience Officer since August 2022.\u00a0Ms. Clark joined us in 2007 and has served as Vice President, Technology Enablement, North American Distribution Group.\u00a0Prior to joining Henry Schein, Ms. Clark held various positions of\u00a0increasing responsibilities at eSurg.\n \n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\n\u00a0\nTable of Contents23 Mark E. Mlotek\u00a0has been our Executive Vice President and Chief Strategic Officer since 2012.\u00a0Mr. Mlotek was Senior Vice President and subsequently Executive Vice President of the Corporate Business Development Group between 2000 and 2012.\u00a0Prior to that, Mr. Mlotek was Vice President, General Counsel and Secretary from 1994 to 1999 and became a director in 1995.\u00a0Prior to joining us, Mr. Mlotek was a partner in the law firm of Proskauer Rose LLP,\u00a0counsel to us, specializing in mergers and acquisitions, corporate reorganizations and tax law from\u00a01989 to 1994. Ronald N. South\u00a0has been our Senior Vice President\u00a0and Chief Financial Officer (and principal financial officer and principal accounting officer) since April 2022.\u00a0Prior to holding his current position, Mr. South was our Corporate Finance and Chief Accounting Officer from 2013 until April 2022.\u00a0Prior to joining us in 2008 as our Vice President, Corporate Finance, Mr. South held leadership roles at Bristol-Myers Squibb, where he served as Vice President, Finance, for the Cardiovascular and Metabolic business lines, as well as Vice President, Controller, for its U.S. Pharmaceutical Division, and Vice President, Corporate General Auditor.\u00a0Prior to Bristol-Myers Squibb, he served as North American Director of Corporate Audit at\u00a0PepsiCo, and held several roles of increasing responsibility with PricewaterhouseCoopers LLP, where he advised clients located in the United States, Europe, and Latin America.\u00a0Mr. South is a certified public accountant. Walter Siegel\u00a0has been our Senior Vice President and Chief Legal Officer since 2021.\u00a0Previously, Mr.\u00a0Siegel was our Senior Vice President and General Counsel from 2013 until 2021.\u00a0Prior to joining us, Mr. Siegel was employed with Standard Microsystems Corporation, a publicly traded global semiconductor\u00a0company from 2005 to 2012, holding positions of increasing responsibility, most recently as Senior Vice President, General Counsel and Secretary. Other Executive Management The following table sets forth certain information regarding other Executive\u00a0Management: Name Age Position Andrea Albertini 52 Chief Executive Officer, International Distribution Group Leigh Benowitz 55 Senior Vice President and Chief Global Digital Transformation Officer\u00a0Trinh Clark 49 Senior Vice President and Chief Global Customer Experience Officer James Mullins 58 Senior Vice President, Global Supply Chain Kelly Murphy 42 Senior Vice President and General Counsel Christopher Pendergast 60 Senior Vice President and Chief Technology Officer Michael Racioppi\u00a068 Senior Vice President, Chief Merchandising Officer Ren\u00e9 Willi, Ph.D. 55 Chief Executive Officer, Global Oral Reconstruction Group Andrea Albertini\u00a0has been Chief Executive Officer, International Distribution Group since 2023.\u00a0Mr. Albertini joined us in 2013 and has held several positions within the organization including\u00a0President, International Distribution Group, President of our EMEA Dental Distribution Group,\u00a0and Vice-President of International Dental Equipment.\u00a0Prior to joining Henry Schein, Mr. Albertini held leadership positions at Cefla Dental Group and Castellini. Leigh Benowitz\u00a0has been our Senior Vice President and Chief Global Digital Transformation Officer since August 2022.\u00a0Ms. Benowitz joined us in 2017 and has held several key positions\u00a0including Vice President Digital & Customer Experience and Global eCommerce Platform Digital Transformation Officer.\u00a0Prior to joining Henry Schein, Ms. Benowitz held various positions with increasing responsibilities\u00a0at Citi. Trinh Clark has been our Senior Vice President and Chief Global Customer Experience Officer since August 2022.\u00a0Ms. Clark joined us in 2007 and has served as Vice President, Technology Enablement, North American Distribution Group.\u00a0Prior to joining Henry Schein, Ms. Clark held various positions of\u00a0increasing responsibilities at eSurg. \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Table of Contents 23  Mark E. Mlotek \u00a0has been our Executive Vice President and Chief Strategic Officer since 2012.\u00a0Mr. Mlotek was  \u00a0 \u00a0 Senior Vice President and subsequently Executive Vice President of the Corporate Business Development Group  between 2000 and 2012.\u00a0Prior to that, Mr. Mlotek was Vice President, General Counsel and Secretary from 1994 to  \u00a0 1999 and became a director in 1995.\u00a0Prior to joining us, Mr. Mlotek was a partner in the law firm of Proskauer  \u00a0 Rose LLP,\u00a0counsel to us, specializing in mergers and acquisitions, corporate reorganizations and tax law from\u00a01989  \u00a0 \u00a0 to 1994.  Ronald N. South \u00a0has been our Senior Vice President\u00a0and Chief Financial Officer (and principal financial officer  \u00a0 \u00a0 and principal accounting officer) since April 2022.\u00a0Prior to holding his current position, Mr. South was our  \u00a0 Corporate Finance and Chief Accounting Officer from 2013 until April 2022.\u00a0Prior to joining us in 2008 as our  \u00a0 Vice President, Corporate Finance, Mr. South held leadership roles at Bristol-Myers Squibb, where he served as  Vice President, Finance, for the Cardiovascular and Metabolic business lines, as well as Vice President, Controller,  for its U.S. Pharmaceutical Division, and Vice President, Corporate General Auditor.\u00a0Prior to Bristol-Myers  \u00a0 Squibb, he served as North American Director of Corporate Audit at\u00a0PepsiCo, and held several roles of increasing  \u00a0 responsibility with PricewaterhouseCoopers LLP, where he advised clients located in the United States, Europe,  and Latin America.\u00a0Mr. South is a certified public accountant.  \u00a0 Walter Siegel \u00a0has been our Senior Vice President and Chief Legal Officer since 2021.\u00a0Previously, Mr.\u00a0Siegel was  \u00a0 \u00a0 \u00a0 our Senior Vice President and General Counsel from 2013 until 2021.\u00a0Prior to joining us, Mr. Siegel was employed  \u00a0 with Standard Microsystems Corporation, a publicly traded global semiconductor\u00a0company from 2005 to 2012,  \u00a0 holding positions of increasing responsibility, most recently as Senior Vice President, General Counsel and  Secretary.  Other Executive Management  The following table sets forth certain information regarding other Executive\u00a0Management:  \u00a0 Name  Age  Position  Andrea Albertini  52  Chief Executive Officer, International Distribution Group  Leigh Benowitz  55  Senior Vice President and Chief Global Digital Transformation Officer\u00a0 \u00a0 Trinh Clark  49  Senior Vice President and Chief Global Customer Experience Officer  James Mullins  58  Senior Vice President, Global Supply Chain  Kelly Murphy  42  Senior Vice President and General Counsel  Christopher Pendergast  60  Senior Vice President and Chief Technology Officer  Michael Racioppi\u00a0 \u00a0 68  Senior Vice President, Chief Merchandising Officer  Ren\u00e9 Willi, Ph.D.  55  Chief Executive Officer, Global Oral Reconstruction Group  Andrea Albertini \u00a0has been Chief Executive Officer, International Distribution Group since 2023.\u00a0Mr. Albertini  \u00a0 \u00a0 joined us in 2013 and has held several positions within the organization including\u00a0President, International  \u00a0 Distribution Group, President of our EMEA Dental Distribution Group,\u00a0and Vice-President of International Dental  \u00a0 Equipment.\u00a0Prior to joining Henry Schein, Mr. Albertini held leadership positions at Cefla Dental Group and  \u00a0 Castellini.  Leigh Benowitz \u00a0has been our Senior Vice President and Chief Global Digital Transformation Officer since August  \u00a0 2022.\u00a0Ms. Benowitz joined us in 2017 and has held several key positions\u00a0including Vice President Digital &  \u00a0 \u00a0 Customer Experience and Global eCommerce Platform Digital Transformation Officer.\u00a0Prior to joining Henry  \u00a0 Schein, Ms. Benowitz held various positions with increasing responsibilities\u00a0at Citi.  \u00a0 Trinh Clark  has been our Senior Vice President and Chief Global Customer Experience Officer since August  2022.\u00a0Ms. Clark joined us in 2007 and has served as Vice President, Technology Enablement, North American  \u00a0 Distribution Group.\u00a0Prior to joining Henry Schein, Ms. Clark held various positions of\u00a0increasing responsibilities at  \u00a0 \u00a0 eSurg. \n\nTable of Contents24 James Mullins\u00a0has been our Senior Vice President of Global Supply Chain since 2018.\u00a0Mr. Mullins joined us in 1988 and has held a number of key positions with increasing responsibility, including Global Chief Customer Service Officer. Kelly Murphy\u00a0has been our Senior Vice President and General Counsel since 2021.\u00a0Since joining us in 2011, Ms. Murphy has held several key positions of increasing responsibility within\u00a0the legal function, most recently serving as Deputy General Counsel.\u00a0Christopher Pendergast\u00a0has been our Senior Vice President and Chief Technology Officer since 2018.\u00a0Prior to joining us, Mr. Pendergast was the employed by VSP Global from 2008 to 2018, most recently as the Chief Technology Officer and Chief Information Officer.\u00a0Prior to VSP Global, Mr. Pendergast served in roles of increasing responsibility at Natural Organics, Inc., from 2006 to 2008, IdeaSphere Inc./Twinlab Corporation from 2000 to 2006, IBM Corporation from 1987 to 1994 and 1998 to 2000\u00a0and Rohm and Haas from 1994 to 1998. Michael Racioppi\u00a0has been our Senior Vice President, Chief Merchandising Officer since 2008.\u00a0Prior to holding his current position, Mr. Racioppi was President of the Medical Division from 2000 to 2008 and Interim President from 1999 to 2000, and Corporate Vice President from 1994 to 2008, with primary responsibility for the Medical Group, Marketing and Merchandising departments.\u00a0Mr. Racioppi served as Senior Director, Corporate Merchandising from 1992 to 1994.\u00a0Before joining us in 1992, Mr. Racioppi was employed by Ketchum Distributors, Inc. as the Vice President of Purchasing and Marketing.\u00a0He currently serves on the board of National Distribution and Contracting and previously served on the board of Health\u00a0Distribution Management Association and Health Industry Distributors Association (HIDA). Ren\u00e9 Willi, Ph.D.\u00a0has been our Chief Executive Officer, Global Oral Reconstruction Group since 2021.\u00a0Previously, Dr.\u00a0Willi was the President of our Global Dental Surgical Group.\u00a0Prior to joining Henry Schein, Dr. Willi held senior level roles with Institut Straumann AG as Executive Vice President, Surgical Business Unit from 2005 to 2013.\u00a0Prior to Straumann, he held roles of increasing responsibility\u00a0in Medtronic Plc\u2019s cardiovascular division from 2003 to 2005 and with McKinsey & Company as\u00a0a management consultant from 2000 to 2003. \n \nTable of Contents24 James Mullins\u00a0has been our Senior Vice President of Global Supply Chain since 2018.\u00a0Mr. Mullins joined us in 1988 and has held a number of key positions with increasing responsibility, including Global Chief Customer Service Officer. Kelly Murphy\u00a0has been our Senior Vice President and General Counsel since 2021.\u00a0Since joining us in 2011, Ms. Murphy has held several key positions of increasing responsibility within\u00a0the legal function, most recently serving as Deputy General Counsel.\u00a0Christopher Pendergast\u00a0has been our Senior Vice President and Chief Technology Officer since 2018.\u00a0Prior to joining us, Mr. Pendergast was the employed by VSP Global from 2008 to 2018, most recently as the Chief Technology Officer and Chief Information Officer.\u00a0Prior to VSP Global, Mr. Pendergast served in roles of increasing responsibility at Natural Organics, Inc., from 2006 to 2008, IdeaSphere Inc./Twinlab Corporation from 2000 to 2006, IBM Corporation from 1987 to 1994 and 1998 to 2000\u00a0and Rohm and Haas from 1994 to 1998. Michael Racioppi\u00a0has been our Senior Vice President, Chief Merchandising Officer since 2008.\u00a0Prior to holding his current position, Mr. Racioppi was President of the Medical Division from 2000 to 2008 and Interim President from 1999 to 2000, and Corporate Vice President from 1994 to 2008, with primary responsibility for the Medical Group, Marketing and Merchandising departments.\u00a0Mr. Racioppi served as Senior Director, Corporate Merchandising from 1992 to 1994.\u00a0Before joining us in 1992, Mr. Racioppi was employed by Ketchum Distributors, Inc. as the Vice President of Purchasing and Marketing.\u00a0He currently serves on the board of National Distribution and Contracting and previously served on the board of Health\u00a0Distribution Management Association and Health Industry Distributors Association (HIDA). Ren\u00e9 Willi, Ph.D.\u00a0has been our Chief Executive Officer, Global Oral Reconstruction Group since 2021.\u00a0Previously, Dr.\u00a0Willi was the President of our Global Dental Surgical Group.\u00a0Prior to joining Henry Schein, Dr. Willi held senior level roles with Institut Straumann AG as Executive Vice President, Surgical Business Unit from 2005 to 2013.\u00a0Prior to Straumann, he held roles of increasing responsibility\u00a0in Medtronic Plc\u2019s cardiovascular division from 2003 to 2005 and with McKinsey & Company as\u00a0a management consultant from 2000 to 2003.  Table of Contents 24  James Mullins \u00a0has been our Senior Vice President of Global Supply Chain since 2018.\u00a0Mr. Mullins joined us in  \u00a0 \u00a0 1988 and has held a number of key positions with increasing responsibility, including Global Chief Customer  Service Officer.  Kelly Murphy \u00a0has been our Senior Vice President and General Counsel since 2021.\u00a0Since joining us in 2011, Ms.  \u00a0 \u00a0 Murphy has held several key positions of increasing responsibility within\u00a0the legal function, most recently serving  \u00a0 as Deputy General Counsel.\u00a0 \u00a0 Christopher Pendergast \u00a0has been our Senior Vice President and Chief Technology Officer since 2018.\u00a0Prior to  \u00a0 \u00a0 joining us, Mr. Pendergast was the employed by VSP Global from 2008 to 2018, most recently as the Chief  Technology Officer and Chief Information Officer.\u00a0Prior to VSP Global, Mr. Pendergast served in roles of  \u00a0 increasing responsibility at Natural Organics, Inc., from 2006 to 2008, IdeaSphere Inc./Twinlab Corporation from  2000 to 2006, IBM Corporation from 1987 to 1994 and 1998 to 2000\u00a0and Rohm and Haas from 1994 to 1998.  \u00a0 Michael Racioppi \u00a0has been our Senior Vice President, Chief Merchandising Officer since 2008.\u00a0Prior to holding  \u00a0 \u00a0 his current position, Mr. Racioppi was President of the Medical Division from 2000 to 2008 and Interim President  from 1999 to 2000, and Corporate Vice President from 1994 to 2008, with primary responsibility for the Medical  Group, Marketing and Merchandising departments.\u00a0Mr. Racioppi served as Senior Director, Corporate  \u00a0 Merchandising from 1992 to 1994.\u00a0Before joining us in 1992, Mr. Racioppi was employed by Ketchum  \u00a0 Distributors, Inc. as the Vice President of Purchasing and Marketing.\u00a0He currently serves on the board of National  \u00a0 Distribution and Contracting and previously served on the board of Health\u00a0Distribution Management Association  \u00a0 and Health Industry Distributors Association (HIDA).  Ren\u00e9 Willi, Ph.D. \u00a0has been our Chief Executive Officer, Global Oral Reconstruction Group since 2021.\u00a0 \u00a0 \u00a0 Previously, Dr.\u00a0Willi was the President of our Global Dental Surgical Group.\u00a0Prior to joining Henry Schein, Dr.  \u00a0 \u00a0 Willi held senior level roles with Institut Straumann AG as Executive Vice President, Surgical Business Unit from  2005 to 2013.\u00a0Prior to Straumann, he held roles of increasing responsibility\u00a0in Medtronic Plc\u2019s cardiovascular  \u00a0 \u00a0 division from 2003 to 2005 and with McKinsey & Company as\u00a0a management consultant from 2000 to 2003.  \u00a0 \n\nTable of Contents25 ITEM 1A. Risk Factors Our business operations could be affected by factors that are not presently known\u00a0to us or that we currently consider not to be material to our operations, so you should not consider\u00a0the risks disclosed in this section to necessarily represent a complete statement of all risks and uncertainties.\u00a0The Company believes that the following risks could have a material adverse impact on our business, reputation, financial\u00a0results, financial condition and/or the trading price of our common stock.\u00a0The order in which these factors appear does not necessarily reflect\u00a0their relative importance or priority.\u00a0COMPANY RISKS Our business, results of operations, cash flows, financial condition and\u00a0liquidity may be negatively impacted by the effects of disease outbreaks, epidemics, pandemics, or similar wide-spread public health\u00a0concerns and other natural disasters.\u00a0The COVID-19 pandemic and the responses of governments\u00a0to it had, and may again have, a material adverse effect on our business, results of operations and cash flows and may result\u00a0in a material adverse effect on our financial condition and liquidity. Our business, results of operations, cash flows, financial condition and\u00a0liquidity may be negatively impacted by the\u00a0effects of disease outbreaks, epidemics, pandemics, similar wide-spread public health concerns\u00a0and other natural disasters. The COVID-19 pandemic has had, and continues to have, an\u00a0unprecedented impact on society, worldwide economic activity, and the health care sector (particularly, the dental market). As a global healthcare solutions company, the COVID-19 pandemic and the governmental responses to it had, and may again have, a material adverse effect on our business, results of operations and cash flows and may result\u00a0in a material adverse effect on our financial condition and liquidity. Even after the COVID-19 pandemic has begun to subside, we may again experience material adverse impacts to our business, results of operations\u00a0and cash flows as a result of, among other things, its global economic impact, including any recession that\u00a0may occur in the future, or a prolonged period of economic slowdown or the reluctance of patients to return for elective dental\u00a0or medical care. The impacts and potential impacts from the COVID-19 pandemic include, but are not\u00a0limited to: \u2022 Significant volatility in supply, demand and selling prices for personal protective equipment (PPE), COVID-19 tests and other COVID-19 related products.\u00a0Available supply,\u00a0customer demand and selling prices for PPE, COVID-19 tests and other COVID-19 related products\u00a0fluctuated in fiscal 2022 and we expect such volatility to continue for the duration of the COVID-19 pandemic. This has resulted\u00a0in inventory reserves, fluctuating margins and increased revenue related to such products.\u00a0The volatility in sales of COVID-19 test kits has moderated,\u00a0albeit at a significantly lower level of sales compared with 2021, resulting in\u00a0us recording an inventory obsolescence reserve of $17 million for COVID-19 test kits during the year\u00a0ended December 31, 2022 and we expect further declines in sales volumes.\u00a0Our estimates for supply, demand and selling prices are inherently uncertain and if supply, demand, selling prices or other market dynamics significantly fluctuate in the future beyond our current assumptions, additional inventory reserves may be required, margins may be reduced and/or\u00a0revenue may decline for such products, each which could materially adversely impact our business,\u00a0results of operations and cash flows. Additionally, governmental policies designed to reduce the transmission of COVID-19 and variants thereof could once again lead to the closure of dental offices or deferral of elective procedures and\u00a0wellness exams by medical and dental patients. Such previous closures and restrictions impacted our\u00a0customers\u2019 spending with us and had, and if reinstated may again have, a material adverse effect on our business, results of operations\u00a0and cash flows.\u00a0Although we believe that most practices currently are able to access\u00a0adequate supply, we still may be unable to supply our customers with the specific brand and/or quantity of certain PPE products,\u00a0COVID-19 tests and other COVID-19 related products they demand, which may lead to our\u00a0customers seeking alternative sources of supply.\u00a0Healthcare professionals\u2019 inability to obtain a sufficient quantity and/or brand of certain PPE, COVID-19\u00a0tests and other COVID-19 related products would adversely impact our business,\u00a0results of operations and cash flows, and could materially adversely affect our financial condition and liquidity; \n \nTable of Contents25 ITEM 1A. Risk Factors Our business operations could be affected by factors that are not presently known\u00a0to us or that we currently consider not to be material to our operations, so you should not consider\u00a0the risks disclosed in this section to necessarily represent a complete statement of all risks and uncertainties.\u00a0The Company believes that the following risks could have a material adverse impact on our business, reputation, financial\u00a0results, financial condition and/or the trading price of our common stock.\u00a0The order in which these factors appear does not necessarily reflect\u00a0their relative importance or priority.\u00a0COMPANY RISKS Our business, results of operations, cash flows, financial condition and\u00a0liquidity may be negatively impacted by the effects of disease outbreaks, epidemics, pandemics, or similar wide-spread public health\u00a0concerns and other natural disasters.\u00a0The COVID-19 pandemic and the responses of governments\u00a0to it had, and may again have, a material adverse effect on our business, results of operations and cash flows and may result\u00a0in a material adverse effect on our financial condition and liquidity. Our business, results of operations, cash flows, financial condition and\u00a0liquidity may be negatively impacted by the\u00a0effects of disease outbreaks, epidemics, pandemics, similar wide-spread public health concerns\u00a0and other natural disasters. The COVID-19 pandemic has had, and continues to have, an\u00a0unprecedented impact on society, worldwide economic activity, and the health care sector (particularly, the dental market). As a global healthcare solutions company, the COVID-19 pandemic and the governmental responses to it had, and may again have, a material adverse effect on our business, results of operations and cash flows and may result\u00a0in a material adverse effect on our financial condition and liquidity. Even after the COVID-19 pandemic has begun to subside, we may again experience material adverse impacts to our business, results of operations\u00a0and cash flows as a result of, among other things, its global economic impact, including any recession that\u00a0may occur in the future, or a prolonged period of economic slowdown or the reluctance of patients to return for elective dental\u00a0or medical care. The impacts and potential impacts from the COVID-19 pandemic include, but are not\u00a0limited to: \u2022 Significant volatility in supply, demand and selling prices for personal protective equipment (PPE), COVID-19 tests and other COVID-19 related products.\u00a0Available supply,\u00a0customer demand and selling prices for PPE, COVID-19 tests and other COVID-19 related products\u00a0fluctuated in fiscal 2022 and we expect such volatility to continue for the duration of the COVID-19 pandemic. This has resulted\u00a0in inventory reserves, fluctuating margins and increased revenue related to such products.\u00a0The volatility in sales of COVID-19 test kits has moderated,\u00a0albeit at a significantly lower level of sales compared with 2021, resulting in\u00a0us recording an inventory obsolescence reserve of $17 million for COVID-19 test kits during the year\u00a0ended December 31, 2022 and we expect further declines in sales volumes.\u00a0Our estimates for supply, demand and selling prices are inherently uncertain and if supply, demand, selling prices or other market dynamics significantly fluctuate in the future beyond our current assumptions, additional inventory reserves may be required, margins may be reduced and/or\u00a0revenue may decline for such products, each which could materially adversely impact our business,\u00a0results of operations and cash flows. Additionally, governmental policies designed to reduce the transmission of COVID-19 and variants thereof could once again lead to the closure of dental offices or deferral of elective procedures and\u00a0wellness exams by medical and dental patients. Such previous closures and restrictions impacted our\u00a0customers\u2019 spending with us and had, and if reinstated may again have, a material adverse effect on our business, results of operations\u00a0and cash flows.\u00a0Although we believe that most practices currently are able to access\u00a0adequate supply, we still may be unable to supply our customers with the specific brand and/or quantity of certain PPE products,\u00a0COVID-19 tests and other COVID-19 related products they demand, which may lead to our\u00a0customers seeking alternative sources of supply.\u00a0Healthcare professionals\u2019 inability to obtain a sufficient quantity and/or brand of certain PPE, COVID-19\u00a0tests and other COVID-19 related products would adversely impact our business,\u00a0results of operations and cash flows, and could materially adversely affect our financial condition and liquidity;  Table of Contents 25 ", "time": "00:00:04"}